106 related articles for article (PubMed ID: 15716074)
1. CD40 signaling induces reciprocal outcomes in Leishmania-infected macrophages; roles of host genotype and cytokine milieu.
Nunes MP; Cysne-Finkelstein L; Monteiro BC; de Souza DM; Gomes NA; DosReis GA
Microbes Infect; 2005 Jan; 7(1):78-85. PubMed ID: 15716074
[TBL] [Abstract][Full Text] [Related]
2. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.
Awasthi A; Mathur R; Khan A; Joshi BN; Jain N; Sawant S; Boppana R; Mitra D; Saha B
J Exp Med; 2003 Apr; 197(8):1037-43. PubMed ID: 12695487
[TBL] [Abstract][Full Text] [Related]
3. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
Srivastava N; Sudan R; Saha B
J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 plays a crucial role in CD40 signaling reciprocity.
Khan TH; Srivastava N; Srivastava A; Sareen A; Mathur RK; Chande AG; Musti KV; Roy S; Mukhopadhyaya R; Saha B
J Immunol; 2014 Oct; 193(7):3644-53. PubMed ID: 25187664
[TBL] [Abstract][Full Text] [Related]
6. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses.
Mathur RK; Awasthi A; Wadhone P; Ramanamurthy B; Saha B
Nat Med; 2004 May; 10(5):540-4. PubMed ID: 15107845
[TBL] [Abstract][Full Text] [Related]
8. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
Andrade RM; Portillo JA; Wessendarp M; Subauste CS
Infect Immun; 2005 May; 73(5):3115-23. PubMed ID: 15845519
[TBL] [Abstract][Full Text] [Related]
9. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
10. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CD40-induced N-Ras activation reduces leishmania major infection.
Chakraborty S; Srivastava A; Jha MK; Nair A; Pandey SP; Srivastava N; Kumari S; Singh S; Krishnasastry MV; Saha B
J Immunol; 2015 Apr; 194(8):3852-60. PubMed ID: 25786685
[TBL] [Abstract][Full Text] [Related]
12. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
Probst P; Skeiky YA; Steeves M; Gervassi A; Grabstein KH; Reed SG
Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
[TBL] [Abstract][Full Text] [Related]
13. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages.
Filardy AA; Pires DR; Nunes MP; Takiya CM; Freire-de-Lima CG; Ribeiro-Gomes FL; DosReis GA
J Immunol; 2010 Aug; 185(4):2044-50. PubMed ID: 20660352
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness.
Sudan R; Srivastava N; Pandey SP; Majumdar S; Saha B
J Immunol; 2012 Mar; 188(5):2328-37. PubMed ID: 22271653
[TBL] [Abstract][Full Text] [Related]
16. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
Stenger S; Solbach W; Röllinghoff M; Bogdan C
Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
[TBL] [Abstract][Full Text] [Related]
17. F₁ cross-breed between susceptible BALB/c and resistant Swiss mice infected with Leishmania major exhibit an intermediate phenotype for lesion sizes and type 1 cytokines but show low level of total IgG antibodies.
Kiige SG; Mutiso JM; Laban LT; Khayeka-Wandabwa C; Anjili CO; Ingonga J; Gicheru MM
Scand J Immunol; 2014 May; 79(5):283-91. PubMed ID: 24498914
[TBL] [Abstract][Full Text] [Related]
18. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40.
DeKruyff RH; Gieni RS; Umetsu DT
J Immunol; 1997 Jan; 158(1):359-66. PubMed ID: 8977211
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
20. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
Bogdan C; Stenger S; Röllinghoff M; Solbach W
Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
